SCIENTURE To Provide REZENOPY To Addiction Treatment Centers

SCIENTURE has entered into an agreement to provide its product REZENOPY™ to around 2,000 Opioid Treatment Program Clinics and other Addiction Treatment Center Networks in the U.S. This move establishes a dedicated commercial channel for the product. According to IQVIA data, the U.S. naloxone market generated approximately $140 million in annual sales, indicating a significant market opportunity.